Clinical study of Traditional Chinese Medicine to Improve the Clinical Benefit Rate of Advanced Esophageal Cancer

Henan Province Hospital of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet the diagnostic criteria of Chinese and Western medicine;
•2. Esophageal cancer patients who cannot undergo surgery, radiotherapy, chemotherapy or disease progression after chemotherapy;
•3. Gender and age are not limited;
•4. The estimated survival time was more than 20 days;
•5. KPS score >= 40;
•6. Those who could take traditional Chinese medicine orally before treatment;
•7. The patient voluntarily signs the informed consent with the informed consent.

•1. Pregnant and lactating women;
•2. Patients with mental illness who are difficult to cooperate with treatment;
•3. Allergy to drugs;
•4. Patients with severe liver, kidney, heart and hematopoietic system diseases;
•5. There was no definite pathological diagnosis;
•6. Have participated in other clinical research;
•7. According to the researcher's judgment, other diseases or conditions that reduce the possibility of enrollment or complicate the enrollment, such as frequent changes in working environment and unstable living environment and other situations that are likely to cause patients to loss to follow-up.

发起方

Henan Province Hospital of TCM